William Gradishar

William Gradishar is the chair of NCCN Breast Cancer Guidelines panel and has been instrumental in translating clinical trial evidence on neoadjuvant and adjuvant therapies into practical treatment algorithms. His expertise spans endocrine therapy, chemotherapy, and targeted therapy selection for early breast cancer including neoadjuvant and adjuvant strategies. He has contributed to educational initiatives that disseminate evidence-based breast cancer management to oncologists nationally. Gradishar leads a multidisciplinary breast cancer program integrating surgery, radiation, and systemic therapy optimization.